Coronavirus: Dexamethasone proves first life-saving drug

A cheap and widely available drug can help save the lives of patients seriously ill with coronavirus. The low-dose steroid treatment dexamethasone is a major breakthrough in the fight against the deadly virus, UK experts say. The drug is part of the world’s biggest trial testing existing treatments to see if they also work for […]

Dexamethasone proves first life-saving drug in treatment of Coronavirus

Categories: Bacteria & Viruses, Conferences & Events, coronavirus, Corporate News, COVID-19, Current Events, Disease Info, Disease Trends, Divisional News, Drug Approvals, Drug News, Eating Habits, Health & Disease, Health & Fitness, Health Kiosk, Health News, Healthy Food, Herbal Trends, Industry News, Infectious Disease, Interactive Media, Local News, Media, Medical News, Press Release

Dexamethasone is a type of corticosteroid medication manufactured by Taj Pharmaceuticals India. It is used in the treatment of many conditions, including COVID-19 respiratory side effects, rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling, eye pain following eye surgery, and along with antibiotics in tuberculosis. In adrenocortical insufficiency, it should be used together with a medication that has greater mineralocorticoid effects such as fludrocortisone.[1] In preterm labor, it may be used to improve outcomes in the baby. It may be taken by mouth, as an injection into a muscle, or intravenously. The effects of dexamethasone are frequently seen within a day and last for about three days.

WHO warning: No evidence that antibody tests can show coronavirus immunity

Categories: Bacteria & Viruses, coronavirus, COVID-19, Disease Info, Disease Trends, Health News, Infectious Disease, Interactive Media, Medical News

The WHO said there’s no evidence serological tests can show whether a person has immunity or is no longer at risk of becoming reinfected. The World Health Organization issued a warning Friday about coronavirus testing, saying there’s no evidence serological tests can show whether a person has immunity or is no longer at risk of becoming reinfected. Bacteria & Viruses, coronavirus, COVID-19, Disease Info, Disease Trends, Drug Approvals, Drug News, Health & Disease, Health News, Industry News, Infectious Disease, Medical News, Press Release

Coronavirus treatment: Vaccines/drugs in the pipeline for COVID-19

Categories: Bacteria & Viruses, coronavirus, COVID-19, Disease Info, Disease Trends, Health & Disease, Health News, Infectious Disease, Medical News, Press Release

The first COVID-19 vaccine in China is expected to be ready for clinical trials by the end of April, according to Xu Nanping, China’s vice-minister of science and technology. Inovio Pharmaceuticals plans to begin clinical trials on a coronavirus vaccine in April this year.

Taj Pharmaceuticals started working on mRNA vaccine against coronavirus

Categories: Bacteria & Viruses, Disease Info, Disease Trends, Drug Approvals, Drug News, Health & Disease, Health News, Industry News, Infectious Disease, Interactive Media, Media, Medical News, Press Release

Taj Pharmaceuticals Biotechnological Division has announced the research in order to create an mRNA vaccine against SARS-COV-2 (coronavirus). Development will be based on previous pipelines for mRNA-oncovaccines creation: an area where the company has a great expertise. The first animal studies are scheduled for the end of April.